Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Inc.

RARE

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Sands Capital Management	Equity	4,163,561	$150,762,544	0.51%	-3.13%
Alkeon Capital Management	Equity	1,685,729	$61,040,248	0.13%	-0.06%
Duquesne Family Office	Equity	85,445	$3,094,000	0.10%	0%

Total Shares Held: 5,934,735

Total Value Reported: $214,896,792

Average Allocation per Portfolio 0.25%

Largest Single Portfolio Allocation: 0.51%

Largest Shareholder: Sands Capital Management

Change in Total Shares Held (Q on Q): -135,429

Percentage Change in Shares Held (Q on Q): -2.23%

Number of Current Holders: 3

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 0

Number of Funds with Deductions (Q on Q): 2

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1